GT Medical Technologies, Inc. today announced it has entered into a strategic distribution partnership with Theragenics Corporation® (Theragenics), a global leader in minimally invasive brachytherapy.

Surmodics, Inc., a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, reported financial results for its second quarter ended March 31, 2024, and updated financial guidance for its fiscal year ending September 30, 2024.

LivaNova PLC, a market-leading medical technology company, reported results for the quarter ended March 31, 2024 and raised full-year 2024 revenue and adjusted diluted earnings per share guidance.

Senseonics Holdings, Inc., a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring systems for people with diabetes, announced that it plans to release its first quarter 2024 financial results after market close on Monday, May 13, 2024.

CooperCompanies announced it will report second quarter 2024 financial results on Thursday, May 30, 2024, at 4:15 PM ET.

The Board of Directors of BD, a leading global medical technology company, announced it has declared a quarterly dividend of $0.95 per common share, payable on June 28, 2024 to holders of record on June 10, 2024.